source Post navigation As researchers push for a type 1 diabetes cure, Sana Biotechnology provides a nudge forward – statnews.com Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis – BioMed Central